Paolo Palma and his colleagues recently published in The Lancet HIV the paper “The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV”
EPPICC was awarded a grant from the ViiV Global HIV and COVID-19 Emergency Fund to conduct research on the direct and indirect impact of COVID-19 on children and adolescents living…
Our collaborator Prof. Mike Sharland, together with GARDP and St. George’s, University of London researchers have just published a new paper in the WHO Bulletin investigating international antibiotic sales data…
Data from the ongoing P1093 and ODYSSEY (PENTA20) studies have led to the successful approval of ViiV Healthcare’s submission to the U.S. Food and Drug Administration (FDA) of the adult formulation…
COVID-19, the new infectious disease which has uprooted our lives, social relationships and work habits, has turned out to be an unmissable opportunity to rethink our collaborative research and strive to drive attention…
COVID-19, the new infectious disease which has uprooted our lives, social relationships and work habits, has turned out to be an unmissable opportunity to rethink our collaborative research and strive to drive attention…